European Capital Markets Institute


You can download the report as well as presentations of speakers from the conference webpage:


Find all information and links to the download here.

A new research report by Diego Valiante (Head of ECMI research): Evidence shows that financial integration in the euro area is retrenching at a quicker pace than outside the union....

Shaping Union in Europe's Capital Markets

The European Capital Markets Institute (ECMI) and the Centre for European Policy Studies (CEPS) are inviting market participants, policy-makers and academics to engage in debate on the future of Europe’s capital markets by joining a Task Force that will work with the European Capital Markets Expert Group (ECMEG). 


ECMI Policy Brief, February 2015: The call for a Capital Markets Union has been a useful device to raise awareness about the need for more integration in Europe's capital markets. Despite years of harmonising regulation and a single currency, Europe’s capital markets remain fragmented. This Policy Brief calls for targeted measures to overcome fragmentation, through enhanced enforcement, strengthening of the European supervisory authorities, enhanced disclosure and comparability of financial information and the mobilisation savings in EU-wide investment funds. 


ECMI Working Paper, September 2014: The market for investment products, including both securities and investment funds, is fraught with difficulties for consumers in terms of the ease of comparing products, trust in suppliers and consumer satisfaction. A comprehensive approach to investor protection, developed around the lifecycle of a financial product, may offer the investor greater protection during an investment’s life span.


ECMI Commentary, May 2014: This commentary provides a snapshot of the current status of the global OTC derivatives markets by: i) identifying general trends over the past decade, ii) looking at the changes in the market structure (instruments and participants), iii) estimating the uncollateralised derivatives exposure and iv) examining the relationship between OTC and ET derivatives.